Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
The Eversense® E3 Smart Transmitter can store up to one year of glucose data.
No glucose readings will be displayed. Always charge immediately when the smart transmitter battery is completely drained. The system will return to Initialization phase if the battery is not charged within 16 hours of a Battery Empty alert.
The mobile app will also display a “No Transmitter Detected” status banner.
| Characteristics | Description |
|---|---|
| Input/Output | 5V DC, 1A |
| Type | USB-A to USB micro-B |
| Length | 36 inches (91 cm) |
The process for inserting the long-term sensor under the skin creates minor tissue changes around the sensor that take some time to return to normal. Twice daily calibrations help support the best possible CGM accuracy during this time.
In the Eversense E3 pivotal clinical trial (PROMISE Study), the system required primarily 1 cal/day, prompting for a median of one-calibration per day 62% of the time, and two calibrations per day 38% of the time, after day 21.
The Eversense® E3 CGM System does has Predictive Alerts. To utilize this feature, you will need to turn it on in the App.
Predictive Alerts let you know in advance that a high or low glucose event is likely to occur if current trends continue.
Predictive Alerts use the Low and High Glucose Alert levels to provide an “early” warning. When you have reached the early warning time, the smart transmitter vibrates, and the mobile app gives an audible alert as well as displays a message on the screen. You should immediately perform a finger stick blood glucose test before making a treatment decision.
To turn this feature ON, tap Menu > Settings > Glucose to display the GLUCOSE SETTINGS screen.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060